Los Angeles Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Los Angeles Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,911	Closed	-$711K	–	1740
2021 Q1	$711K	Sell	8,911 -671	-7%	-$52.4K	﹤0.01%	1066
2020 Q4	$756K	Buy	+9,582	New	+$562K	﹤0.01%	1049
2019 Q2	–	Sell	-314,138	Closed	-$21M	–	1476
2019 Q1	$21M	Sell	314,138 -13,220	-4%	-$1M	0.12%	185
2018 Q4	$24.4M	Sell	327,358 -31,361	-9%	-$2.59M	0.15%	154
2018 Q3	$33M	Buy	358,719 +335,445	+1,441%	+$32M	0.17%	146
2018 Q2	$2.29M	Sell	23,274 -410	-2%	-$45.9K	0.01%	656
2018 Q1	$2.64M	Buy	23,684 +125	+0.5%	+$14K	0.02%	570
2017 Q4	$2.42M	Buy	23,559 +11,350	+93%	+$1.13M	0.01%	613
2017 Q3	$1.15M	Buy	12,209 +9,080	+290%	+$717K	0.01%	775
2017 Q2	$244K	Buy	3,129 +350	+13%	+$26.3K	﹤0.01%	1116
2017 Q1	$223K	Buy	+2,779	New	+$221K	﹤0.01%	1074

Los Angeles Capital Management's CMD Position: Q2 2021 in Review

Los Angeles Capital Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 8,911 shares — an estimated $711K sold.

Los Angeles Capital Management first reported a position in CMD in Q1 2017 and held it in 11 quarters. The position peaked at $33M in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

Los Angeles Capital Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
Los Angeles Capital Management sold 8,911 Cantel Medical Corporation shares in Q2 2021, an estimated $711K.
Los Angeles Capital Management first reported a position in Cantel Medical Corporation in Q1 2017 and held it in 11 quarters.
Los Angeles Capital Management's Cantel Medical Corporation position peaked at $33M in Q3 2018.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.